Results     31-May-21
Announcements
Marksans Pharma consolidated net profit rises 86.01% in the March 2021 quarter
Sales decline 1.54% to Rs 330.20 crore
Net profit of Marksans Pharma rose 86.01% to Rs 79.50 crore in the quarter ended March 2021 as against Rs 42.74 crore during the previous quarter ended March 2020. Sales declined 1.54% to Rs 330.20 crore in the quarter ended March 2021 as against Rs 335.35 crore during the previous quarter ended March 2020.

For the full year,net profit rose 97.55% to Rs 238.54 crore in the year ended March 2021 as against Rs 120.75 crore during the previous year ended March 2020. Sales rose 21.33% to Rs 1376.18 crore in the year ended March 2021 as against Rs 1134.21 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear Ended
 Mar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.
Sales330.20335.35 -2 1376.181134.21 21
OPM %28.8920.63 -24.6816.95 -
PBDT98.5667.19 47 338.32183.84 84
PBT97.2257.56 69 302.16157.17 92
NP79.5042.74 86 238.54120.75 98

Previous News
  Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
 ( Results - Announcements 20-May-25   07:46 )
  Marksans Pharma to declare Quarterly Result
 ( Corporate News - 17-Jan-24   17:29 )
  Marksans Pharma receives affirmation in credit ratings
 ( Corporate News - 07-Feb-23   12:46 )
  Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets
 ( Corporate News - 02-Aug-24   16:12 )
  Marksans Pharma gains after arm gets nod for Baclofen tablets from UK MHRA
 ( Hot Pursuit - 19-Mar-25   12:50 )
  Nifty below 17,400 level; bank stocks under pressure
 ( Market Commentary - Mid-Session 10-Mar-23   14:37 )
  Equity barometers hit fresh intraday low; PSU bank shares witness profit booking
 ( Market Commentary - Mid-Session 19-Apr-23   14:36 )
  Marksans Pharma to convene AGM
 ( Corporate News - 11-Aug-21   18:44 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 20-May-25   12:49 )
  Relonchem receives marketing authorization for Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets
 ( Corporate News - 25-Feb-25   12:31 )
  Board of Marksans Pharma recommends final dividend
 ( Corporate News - 02-Jun-20   17:55 )
Other Stories
  Parle Industries reports consolidated net profit of Rs 0.04 crore in the March 2025 quarter
  21-Jun-25   07:32
  Aegis Logistics consolidated net profit rises 43.50% in the March 2025 quarter
  20-Jun-25   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 31.44 crore in the March 2025 quarter
  18-Jun-25   07:29
  Dhelakhat Tea Co reports standalone net loss of Rs 3.11 crore in the March 2025 quarter
  18-Jun-25   07:29
  Kant & Company reports standalone net loss of Rs 0.12 crore in the March 2025 quarter
  18-Jun-25   07:29
  Indo Eco (India) reports standalone net profit of Rs 0.01 crore in the March 2025 quarter
  18-Jun-25   07:29
  Purshottam Investofin reports standalone net loss of Rs 0.91 crore in the March 2025 quarter
  18-Jun-25   07:29
  Indrayani Biotech reports consolidated net loss of Rs 5.81 crore in the March 2025 quarter
  17-Jun-25   07:29
  Vipul reports consolidated net loss of Rs 34.95 crore in the March 2025 quarter
  17-Jun-25   07:29
  Adarsh Mercantile reports consolidated net profit of Rs 2.60 crore in the March 2025 quarter
  17-Jun-25   07:29
Back Top